IL-1Ra, by competitive binding of IL-1 type 1 receptor (IL-1R), can be an immunomodulatory strategy for fungal infections where disease and pathology are the result of inflammation-driven collateral damage (e.g. VVC, pulmonary aspergillosis, or influenza-associated pulmonary aspergillosis). Here, IL1R1 is linked to fungal infectious disease.